BBPvsPTHETF Comparison
VS
Virtus LifeSci Biotech Products ETF (BBP) belongs to the Tomorrow's Treatments segment. Invesco DWA Healthcare Momentum ETF (PTH) is part of the US Health Care segment. BBP's top 1 sector exposures are Healthcare. In contrast, PTH's top sector exposures are Healthcare and Consumer Non-Cyclicals. BBP is less expensive with a Total Expense Ratio (TER) of 0.34%, versus 0.72% for PTH. BBP is up 32.02% year-to-date (YTD) with +$50M in YTD flows. PTH performs worse with 23.57% YTD performance, and +$131M in YTD flows. Run a side-by-side ETF comparison of BBP and PTH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
BBP vs PTH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/09/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | BBP PTH | +4.09%+0.74% | +23.23%+22.99% | +32.02%+23.57% | +49.71%+54.68% | +98.63%+72.09% | +100.65%+9.07% |
| Flows | BBP PTH | +$5M+$26M | +$20M+$142M | +$50M+$131M | +$62M+$138M | +$68M+$78M | +$61M-$151M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | BBP PTH | +25.85%+28.82% | +25.14%+26.08% | +24.72%+26.02% | +26.61%+25.76% |
| Max drawdown | BBP PTH | -9.34%-7.42% | -9.59%-11.91% | -25.54%-27.71% | -37.61%-49.87% |
| Max drawdown duration | BBP PTH | 39d40d | 48d140d | 292d353d | 586d1735d |
Trading data
BBP | PTH | |
Last sale 9/10/2026 at 2:58 PM | $103.97 | $61.31 |
| Previous close 09/09/2026 | $105.52 | $61.46 |
| Consolidated volume 09/09/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
BBP | PTH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/10/2026 at 2:58 PM
Live
Closed
BBP | PTH | |
|---|---|---|
| Last price | $103.97 | $61.31 |
| 1D performance | -1.47% | -0.24% |
| AuM | $115.83 M | $286.88 M |
| E/R | 0.34% | 0.72% |
Characteristics
BBP | PTH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | VIRTUS Investment Partners | Invesco |
| Benchmark | LifeSci Biotechnology Products Index | Dorsey Wright Healthcare Technical Leaders Index |
| N° of holdings | 66 | 54 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | December 16, 2014 | October 12, 2006 |
| ESG | No | No |
Advertisement
Exposure
Countries
BBP
USA
86.5%
Other
13.5%
PTH
USA
89.98%
Other
10.02%
Sectors
BBP
Healthcare
98.2%
Other
1.8%
PTH
Healthcare
99.16%
Other
0.84%
Advertisement
Diversification
BBP
Total weight of top 15 holdings out of 15
26.78%
PTH
Total weight of top 15 holdings out of 15
47.09%
Top 15 holdings
Data as of July 31, 2026
BBP
Crinetics Pharmaceuticals, Inc.
3.24%
Verastem, Inc.
1.98%
Nuvation Bio, Inc.
1.80%
Omeros Corp.
1.73%
Geron Corp.
1.72%
BridgeBio Pharma, Inc.
1.68%
Agios Pharmaceuticals, Inc.
1.67%
Protagonist Therapeutics, Inc.
1.65%
BeOne Medicines Ltd.
1.64%
Kiniksa Pharmaceuticals International Plc
1.63%
Precigen, Inc.
1.62%
Xeris Biopharma Holdings, Inc.
1.61%
ACADIA Pharmaceuticals, Inc.
1.60%
Iovance Biotherapeutics, Inc.
1.60%
Rhythm Pharmaceuticals, Inc.
1.60%
PTH
Roivant Sciences Ltd.
4.88%
Revolution Medicines, Inc.
4.85%
BrightSpring Health Services, Inc.
4.77%
Guardant Health, Inc.
4.50%
Axsome Therapeutics, Inc.
4.38%
Liquidia Corp.
3.17%
Erasca, Inc.
2.92%
Oruka Therapeutics, Inc.
2.54%
10X Genomics, Inc.
2.27%
Relay Therapeutics, Inc.
2.23%
Travere Therapeutics, Inc.
2.18%
Agilon Health, Inc.
2.13%
Oscar Health, Inc.
2.09%
Arrowhead Pharmaceuticals, Inc.
2.09%
Tango Therapeutics, Inc.
2.09%
Frequently asked questions about BBP and PTH
How have the BBP and PTH ETFs performed in 2026?
As of September 9, 2026, BBP is up 32.02% year-to-date (YTD), while PTH has returned 23.57%. That puts BBP better performer ahead so far this year.
Which ETF is attracting more investor money: BBP or PTH?
Year-to-date, the BBP ETF saw +$50M in flows, compared to +$131M for PTH.
Which ETF is more volatile: BBP or PTH?
Over the past year, BBP had a volatility of 25.14%, while PTH experienced 26.08%.
Which ETF is bigger: BBP or PTH?
As of September 9, 2026, BBP holds $115.83 M in assets under management (AUM), while PTH manages $286.88 M.
What sectors do the BBP and PTH ETFs invest in?
BBP leans toward sectors like Healthcare. Meanwhile, PTH focuses on Healthcare.
What are the top holdings of the BBP ETF and PTH ETF?
BBP top holdings include Crinetics Pharmaceuticals, Inc., Verastem, Inc. and Nuvation Bio, Inc.. PTH holds in its top three: Roivant Sciences Ltd., Revolution Medicines, Inc. and BrightSpring Health Services, Inc..
Which ETF is more diversified: BBP or PTH?
BBP holds 66 securities with 26.78% of its assets in the top 15. PTH has 54 securities and a top 15 weight of 47.09%.
Advertisement
Latest news about BBP & PTH
Advertisement
